Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Feb;64(2):116-26.
doi: 10.1016/S0011-393X(03)00016-X.

Physicians' perceptions of factors influencing adherence to antibiotic prophylaxis in children with sickle cell disease

Affiliations

Physicians' perceptions of factors influencing adherence to antibiotic prophylaxis in children with sickle cell disease

Keele E Wurst et al. Curr Ther Res Clin Exp. 2003 Feb.

Abstract

Background: Children with sickle cell disease (SCD) aged <5 years are at great risk for invasive infection with Staphylococcus pneumoniae and Haemophilus influenzae due to the inability of their spleen to protect against infection.

Objectives: This study examined (1) physicians' perceptions of factors associated with adherence to antibiotic prophylaxis in children with SCD and (2) how physician characteristics are associated with these perceptions.

Methods: A MEDLINE search of the years 1996 to 2002, using the terms sickle cell disease, compliance, children, physician perceptions, and antibiotic prophylaxis, was done. A survey was developed using existing literature to assess physicians' perceptions of factors associated with adherence to antibiotic prophylaxis for SCD. The survey was sent to a stratified random sample of 375 pediatricians and all 125 practicing hematologists in North Carolina. They were given a Likert-type scale to assess their perceptions of factors that influence patients' adherence to antibiotic prophylaxis for SCD. Physician demographic information was collected using the North Carolina Health Professions Data Book. The demographic information was matched to the survey respondent and correlated with his or her responses.

Results: The response rate was 56.9%. Of the respondents, 60.9% were pediatricians, and 56.5% were in a practice with at least 1 patient aged <5 years with SCD. Physician race and practice specialty were significantly associated with factors physicians considered very important to adherence.

Conclusions: Most physicians agree on many issues that affect adherence; however, significant and important differences exist, based on physician ethnicity. Physicians' perceptions of factors that affect adherence in this study did not always agree with factors demonstrated to actually affect adherence in SCD patients. Therefore, this study indicates a need for physician continuing-education programs that focus on factors that actually influence adherence of antibiotic prophylaxis and the racial/ethnic backgrounds of the providers in relation to the patient.

Keywords: adherence; antibiotics; physician perceptions; sickle cell disease.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Sickle Cell Disease Guideline Panel . Clinical Practice Guideline No. 6: Sickle Cell Disease: Screening, Diagnosis, Management, and Counseling in Newborns and Infants. Agency for Health Care Policy and Research; Public Health Service, US Department of Health and Human Services; Rockville, Md: 1993. AHCPR publication 93-0562.
    1. Overturf G.D. Infections and immunizations of children with sickle cell disease. Adv Pediatr Infect Dis. 1999;14:191–218. - PubMed
    1. Gaston M.H, Verter J.I, Woods G. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med. 1986;314:1593–1599. - PubMed
    1. Teach S.J, Lillis K.A, Grossi M. Compliance with penicillin prophylaxis in patients with sickle cell disease. Arch Pediatr Adolesc Med. 1998;152:274–278. - PubMed
    1. Berkovitch M, Papadouris D, Shaw D. Trying to improve compliance with prophylactic penicillin therapy in children with sickle cell disease. Br J Clin Pharmacol. 1998;45:605–607. - PMC - PubMed

LinkOut - more resources